Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Duygu Temiz KaradağAndac KomacYesim ErezAhmet Merih BirlikAlper SariAli AkdoğanBayram FarisogullariGezmiş KimyonEmrah KocDidem ArslanAhmet KaratasSuleyman Serdar KocaNilgün KasifogluAyten YaziciKadir Mutlu HayranAyse CeflePublished in: Immunity, inflammation and disease (2023)
Based on our results, coexpression of autoantibodies is not uncommon in SSc patients. Although autoantibodies specific to SSc in early disease show generally known clinical features, it remains to be investigated how the coexpression of autoantibodies will affect clinical presentation.
Keyphrases
- systemic sclerosis
- early stage
- systemic lupus erythematosus
- interstitial lung disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- network analysis
- patient reported outcomes
- mass spectrometry
- high resolution
- idiopathic pulmonary fibrosis
- patient reported
- neoadjuvant chemotherapy